HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Ogihara Selected Research

Obesity

6/2006Beneficial effects of candesartan, an angiotensin II type 1 receptor blocker, on beta-cell function and morphology in db/db mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Ogihara Research Topics

Disease

19Type 2 Diabetes Mellitus (MODY)
01/2019 - 01/2002
6Insulin Resistance
11/2013 - 07/2004
4Inflammation (Inflammations)
07/2015 - 06/2010
3Hyperglycemia
01/2019 - 06/2010
3Diabetic Nephropathies (Diabetic Nephropathy)
03/2003 - 01/2002
2Insulinoma
03/2018 - 01/2009
2Hypoglycemia (Reactive Hypoglycemia)
12/2017 - 03/2017
2Albuminuria
01/2017 - 03/2003
1Weight Gain
12/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2015
1Amyloid Plaque
08/2014
1Glucose Intolerance
06/2010
1Atherosclerosis
07/2007
1Hypercholesterolemia
06/2007
1Obesity
06/2006
1Fibrosis (Cirrhosis)
06/2006

Drug/Important Bio-Agent (IBA)

8Insulin (Novolin)FDA Link
01/2019 - 01/2007
5CytokinesIBA
07/2015 - 06/2010
3Glucose (Dextrose)FDA LinkGeneric
02/2016 - 06/2007
2Small Interfering RNA (siRNA)IBA
03/2018 - 01/2009
2VildagliptinIBA
12/2017 - 03/2017
2Glycoside Hydrolase InhibitorsIBA
11/2013 - 07/2007
2CreatinineIBA
03/2003 - 01/2002
1Glucagon (Glukagon)FDA Link
01/2019
1anagliptinIBA
01/2019
1Bromodeoxyuridine (BrdU)IBA
03/2018
1Hypoglycemic Agents (Hypoglycemics)IBA
12/2017
1Metformin (Glucophage)FDA LinkGeneric
12/2017
1Alanine Transaminase (SGPT)IBA
01/2017
1A-130A (A 130)IBA
01/2017
1insulin degludecIBA
01/2015
1Islet Amyloid PolypeptideIBA
08/2014
1Liposomes (Liposome)IBA
11/2013
1Clodronic Acid (Clodronate)IBA
11/2013
1Dipeptidyl-Peptidase IV InhibitorsIBA
11/2013
1Glucagon-Like Peptide 1 (GLP 1)IBA
11/2013
1Pioglitazone (Actos)FDA Link
02/2012
1EnzymesIBA
12/2010
1deoxyhypusine synthaseIBA
12/2010
1Amyloid (Amyloid Fibrils)IBA
08/2010
1hypusineIBA
06/2010
1Messenger RNA (mRNA)IBA
06/2010
1Streptozocin (Streptozotocin)FDA Link
06/2010
1Proteins (Proteins, Gene)FDA Link
01/2009
1Pyruvic Acid (Pyruvate)IBA
08/2008
1ElementsIBA
08/2008
1Carrier Proteins (Binding Protein)IBA
08/2008
1Phosphotransferases (Kinase)IBA
08/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2008
1PPAR gammaIBA
08/2008
1Blood Glucose (Blood Sugar)IBA
07/2007
1ApolipoproteinsIBA
07/2007
1Pravastatin (Pravachol)FDA LinkGeneric
06/2007
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2007
1Atorvastatin (Lipitor)FDA Link
06/2007
1Eicosapentaenoic AcidIBA
03/2007
1Angiotensin II Type 1 Receptor BlockersIBA
06/2006
1candesartanIBA
06/2006
1Nitric Oxide Synthase (NO Synthase)IBA
07/2004
1Chemokine CCL5IBA
03/2003
1CCR5 Receptors (CCR5 Receptor)IBA
03/2003
1Superoxide DismutaseIBA
01/2003
1Valine (L-Valine)FDA Link
01/2003
1Alanine (L-Alanine)FDA Link
01/2003
1Chemokine ReceptorsIBA
01/2002

Therapy/Procedure

6Glycemic Control
12/2017 - 11/2013
3Therapeutics
03/2017 - 06/2007
2Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
01/2017 - 01/2017
1Injections
01/2015